ARTICLE | Company News
XenoPharm, Bristol-Myers deal
August 27, 2001 7:00 AM UTC
XenoPharm will test an undisclosed number of BMY compounds for their induction of drug metabolism enzyme expression. XenoPharm uses its XenoSensor technology, steroid X receptor, constitutive androst...